enow.com Web Search

  1. Ads

    related to: castration resistant prostate cancer cells go to lymph nodes
    • Follicular Lymphoma

      Follicular Lymphoma Treatment Guide

      Find Follicular Lymphoma Options

    • B-Cell Lymphoma

      B-Cell Lymphoma Treatment Guide

      B-Cell Lymphoma Treatment Options

Search results

  1. Results from the WOW.Com Content Network
  2. Prostate cancer - Wikipedia

    en.wikipedia.org/wiki/Prostate_cancer

    Eventually cancer cells can grow resistant to this treatment. This most-advanced stage of the disease, called castration-resistant prostate cancer, is treated with continued hormone therapy alongside the chemotherapy drug docetaxel. Some tumors metastasize (spread) to other areas of the body, particularly the bones and lymph nodes.

  3. DU145 - Wikipedia

    en.wikipedia.org/wiki/DU145

    DU145, PC3, and LNCaP are considered to be the standard prostate cancer cell lines used in therapeutic research. [ 1 ] The DU145 cell line was derived from a central nervous system metastasis , of primary prostate adenocarcinoma origin, removed during a parieto-occipital craniotomy of a 69-year-old, White, male.

  4. LNCaP - Wikipedia

    en.wikipedia.org/wiki/LNCaP

    The LNCaP (Lymph Node Carcinoma of the Prostate) cell line was established from a metastatic lesion of human prostatic adenocarcinoma.The LNCaP cells grow readily in vitro (up to 8 x 10 5 cells/sq cm; doubling time, 60 hr), form clones and are highly resistant to human fibroblast interferon. [1]

  5. Sipuleucel-T - Wikipedia

    en.wikipedia.org/wiki/Sipuleucel-T

    Other names for this stage are metastatic castrate-resistant (mCRPC) and androgen independent (AI) or (AIPC). This stage leads to mCRPC with lymph node involvement and distal (distant) tumors; this is the lethal stage of CaP. The prostate cancer staging designation is T4,N1,M1c. [5] [6] [7]

  6. Opevesostat - Wikipedia

    en.wikipedia.org/wiki/Opevesostat

    Opevesostat is an investigational new drug being developed for the treatment of metastatic castration-resistant prostate cancer (mCRPC). [1] It is a non-steroidal, selective inhibitor of CYP11A1 (cholesterol side-chain cleavage enzyme) [2] discovered by Orion Corporation and currently undergoing clinical development by Merck & Co., Inc. Opevesostat's mechanism of action involves suppressing ...

  7. PC3 - Wikipedia

    en.wikipedia.org/wiki/PC3

    PC3 cells have been utilized to research aggressive and castration-resistant forms of pancreatic cancer. The androgen-independence of these cells during cell division makes them invaluable for studying the molecular mechanisms embedded in studying advanced prostate cancer. [13] PC3 cells have been involved in research regarding the prevention ...

  1. Ads

    related to: castration resistant prostate cancer cells go to lymph nodes